David Owen Baumann

Title: David Owen Baumann: Innovator in Peptoid-Based Chelating Ligands

Introduction

David Owen Baumann is a notable inventor based in Los Alamos, NM (US). He holds three patents, showcasing his contributions to the field of chemistry and materials science. His work primarily focuses on the development of peptoid-based chelating ligands, which have significant applications in medical and environmental fields.

Latest Patents

Baumann's latest patents include innovative peptoid-based chelating ligands designed for selective metal chelation. These ligands are characterized by their tailored functional groups that provide high metal binding affinity and selectivity. The cyclic peptoids can be customized to exhibit high affinity for actinide or other metal ions, making them valuable for treating metal poisoning and for use in medical imaging, chelation therapy, drug delivery, and separation technologies. Unlike traditional siderophores, these peptoid-based ligands are stable under physiological conditions, enhancing their practical applications.

Career Highlights

Throughout his career, Baumann has worked with Triad National Security, LLC, contributing to various research initiatives. His expertise in the field has led to significant advancements in the development of chelating agents that can effectively bind and recover metals from biological systems.

Collaborations

Baumann has collaborated with notable colleagues, including Robert F. Williams and John Cameron Gordon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the scientific community.

Conclusion

David Owen Baumann's work in developing peptoid-based chelating ligands represents a significant advancement in the field of chemistry. His contributions have the potential to impact medical treatments and environmental applications positively.